Cited 29 times in
Economic and patient-reported outcomes of outpatient home-based versus inpatient hospital-based chemotherapy for patients with colorectal cancer
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 라선영 | - |
dc.contributor.author | 안중배 | - |
dc.date.accessioned | 2014-12-20T16:52:28Z | - |
dc.date.available | 2014-12-20T16:52:28Z | - |
dc.date.issued | 2011 | - |
dc.identifier.issn | 0941-4355 | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/93542 | - |
dc.description.abstract | PURPOSE: This study aims to compare the economic- and patient-reported outcomes between outpatient home-based and inpatient hospital-based chemotherapy in advanced colorectal cancer patients. METHODS: A total of 80 patients from Severance Hospital in Seoul, Korea, who had stage III colorectal cancer and underwent home-based (n = 40) or hospital-based chemotherapy (n = 40) with a FOLFOX regimen between January 2007 and April 2008 were enrolled. Patient satisfaction data were collected by a self-administered questionnaire survey. Based on hospital charge records, average cost (in 2008 Korean won (KW)) per chemotherapy session was estimated and compared between home- and hospital-based chemotherapy from a societal perspective. RESULTS: Patients receiving chemotherapy at home showed higher satisfaction with their treatment (mean satisfaction score 3.58 ± 0.15, 5-point Likert-type scale, with a higher score indicating higher satisfaction) than did those treated at the hospital (3.23 ± 0.21; p < 0.01). After adjusting for differences in baseline characteristics between the two groups using multivariate analysis, those receiving home-based chemotherapy still showed significantly higher satisfaction than those undergoing hospital-based therapy (β = 0.271, p < 0.001). Additionally, home-based therapy reduced the cost per chemotherapy session by 16.6%, compared with hospital-based treatment (1,694,216 versus 2,030,383 KW, 1,200 KW ≈ 1 US dollar). The largest cost reduction was attributable to medical costs (-201,122 KW), followed by caregiver's opportunity costs (-135,000 KW). CONCLUSIONS: Higher satisfaction and lower economic cost for home-based chemotherapy suggests that home-based chemotherapy could be a popular and cost-effective treatment option for colorectal cancer patients who are eligible for home-based chemotherapy | - |
dc.description.statementOfResponsibility | open | - |
dc.format.extent | 971~978 | - |
dc.relation.isPartOf | SUPPORTIVE CARE IN CANCER | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/2.0/kr/ | - |
dc.subject.MESH | Aged | - |
dc.subject.MESH | Antineoplastic Agents/economics* | - |
dc.subject.MESH | Antineoplastic Agents/therapeutic use | - |
dc.subject.MESH | Antineoplastic Combined Chemotherapy Protocols/economics | - |
dc.subject.MESH | Antineoplastic Combined Chemotherapy Protocols/therapeutic use | - |
dc.subject.MESH | Colorectal Neoplasms/drug therapy* | - |
dc.subject.MESH | Colorectal Neoplasms/economics | - |
dc.subject.MESH | Cost-Benefit Analysis | - |
dc.subject.MESH | Female | - |
dc.subject.MESH | Fluorouracil/economics | - |
dc.subject.MESH | Fluorouracil/therapeutic use | - |
dc.subject.MESH | Focus Groups | - |
dc.subject.MESH | Health Surveys | - |
dc.subject.MESH | Home Care Services/economics* | - |
dc.subject.MESH | Home Care Services/statistics & numerical data | - |
dc.subject.MESH | Humans | - |
dc.subject.MESH | Inpatients/statistics & numerical data* | - |
dc.subject.MESH | Leucovorin/economics | - |
dc.subject.MESH | Leucovorin/therapeutic use | - |
dc.subject.MESH | Male | - |
dc.subject.MESH | Middle Aged | - |
dc.subject.MESH | Multivariate Analysis | - |
dc.subject.MESH | Organoplatinum Compounds/economics | - |
dc.subject.MESH | Organoplatinum Compounds/therapeutic use | - |
dc.subject.MESH | Outpatients/statistics & numerical data* | - |
dc.subject.MESH | Patient Satisfaction/statistics & numerical data | - |
dc.subject.MESH | Regression Analysis | - |
dc.subject.MESH | Republic of Korea | - |
dc.subject.MESH | Self Report/economics* | - |
dc.subject.MESH | Statistics as Topic | - |
dc.subject.MESH | Surveys and Questionnaires | - |
dc.title | Economic and patient-reported outcomes of outpatient home-based versus inpatient hospital-based chemotherapy for patients with colorectal cancer | - |
dc.type | Article | - |
dc.contributor.college | College of Medicine (의과대학) | - |
dc.contributor.department | Dept. of Internal Medicine (내과학) | - |
dc.contributor.googleauthor | Eun-Hye Joo | - |
dc.contributor.googleauthor | Sun-Young Rha | - |
dc.contributor.googleauthor | Joong Bae Ahn | - |
dc.contributor.googleauthor | Hye-Young Kang | - |
dc.identifier.doi | 10.1007/s00520-010-0917-7 | - |
dc.admin.author | false | - |
dc.admin.mapping | false | - |
dc.contributor.localId | A02262 | - |
dc.contributor.localId | A01316 | - |
dc.relation.journalcode | J02697 | - |
dc.identifier.eissn | 1433-7339 | - |
dc.identifier.pmid | 20496154 | - |
dc.identifier.url | http://link.springer.com/article/10.1007%2Fs00520-010-0917-7 | - |
dc.subject.keyword | Chemotherapy | - |
dc.subject.keyword | Colorectal cancer | - |
dc.subject.keyword | Cost | - |
dc.subject.keyword | Home infusion therapy | - |
dc.subject.keyword | Outcome | - |
dc.subject.keyword | Patient satisfaction | - |
dc.contributor.alternativeName | Rha, Sun Young | - |
dc.contributor.alternativeName | Ahn, Joong Bae | - |
dc.contributor.affiliatedAuthor | Ahn, Joong Bae | - |
dc.contributor.affiliatedAuthor | Rha, Sun Young | - |
dc.rights.accessRights | not free | - |
dc.citation.volume | 19 | - |
dc.citation.number | 7 | - |
dc.citation.startPage | 971 | - |
dc.citation.endPage | 978 | - |
dc.identifier.bibliographicCitation | SUPPORTIVE CARE IN CANCER, Vol.19(7) : 971-978, 2011 | - |
dc.identifier.rimsid | 28297 | - |
dc.type.rims | ART | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.